Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Armodafinil | Panax Ginseng | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 75-150 mg once daily (for educational context only — prescription medication in most jurisdictions) | 200-400 mg/day of standardized extract (4-7% ginsenosides, typically G115 brand) or 1-2 g/day of dried root |
| Timing | Early morning. 150 mg armodafinil provides comparable late-day wakefulness to 200 mg modafinil. Food delays Tmax by ~2-4 hours but does not affect total absorption. Half-life approximately 15-16.5 hours. | Morning on an empty stomach or with food. Avoid evening dosing due to mild stimulatory effects. Acute cognitive effects noted within 1-4 hours of dosing. |
| Cycle Duration | Same as modafinil; not typically cycled in clinical use. | Traditionally cycled 2-3 weeks on, 1-2 weeks off. Long-term continuous use exceeding 3 months is debated. |
| Evidence Level | strong_human | moderate_human |
The isolated R-enantiomer of racemic modafinil, sharing the same primary mechanism — selective inhibition of the dopamine transporter (DAT) — but with distinct pharmacokinetics. The R-enantiomer has a terminal half-life of ~15 hours vs. ~4-5 hours for the S-enantiomer, resulting in 33-40% higher plasma AUC compared to equimolar racemic modafinil. This translates to more sustained wakefulness-promoting activity throughout the day. Same downstream activation of orexinergic, histaminergic, and noradrenergic pathways as modafinil.
75-150 mg once daily (for educational context only — prescription medication in most jurisdictions)
Early morning. 150 mg armodafinil provides comparable late-day wakefulness to 200 mg modafinil. Food delays Tmax by ~2-4 hours but does not affect total absorption. Half-life approximately 15-16.5 hours.
Same as modafinil; not typically cycled in clinical use.
Ginsenosides (primarily Rg1, Rb1, Re) are amphipathic steroidal saponins that modulate multiple neurotransmitter systems: enhancement of cholinergic transmission via increased acetylcholine synthesis and release; activation of PI3K/Akt and CREB/BDNF signaling pathways to promote neurogenesis and synaptic plasticity; attenuation of neuroinflammation through Keap1/Nrf2 signaling and suppression of the NF-kB/NLRP3 inflammasome axis; and regulation of the HPA axis to buffer cortisol response to stress. Protopanaxadiol and protopanaxatriol ginsenosides have opposing modulatory effects on GABA-A receptors.
200-400 mg/day of standardized extract (4-7% ginsenosides, typically G115 brand) or 1-2 g/day of dried root
Morning on an empty stomach or with food. Avoid evening dosing due to mild stimulatory effects. Acute cognitive effects noted within 1-4 hours of dosing.
Traditionally cycled 2-3 weeks on, 1-2 weeks off. Long-term continuous use exceeding 3 months is debated.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →